Skip to main content

CVRx, Inc. (CVRX) Stock Forecast

Data as of Aug 8, 2026

Healthcare · Current price $2.37 (-60.10%)

Consensus Target
$10.00
Upside
+127.0%
Analysts
2
Rating
Buy(2.00)

Price Target Range

Low $10.00High $10.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

CVRX vs Sector & Market

MetricCVRXHealthcare AvgLarge Cap Avg
Analyst Rating2.002.252.42
Analyst Count2818
Target Upside+127.0%+16286.3%+14.7%
P/E Ratio-3.683.5936.06

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$65M$65M$65M5
2027-03-31$17M$17M$17M1
2027-06-30$18M$18M$19M2
2027-09-30$20M$20M$20M2
2027-12-31$21M$21M$22M1
2028-03-31$22M$22M$23M1
2028-06-30$24M$24M$25M1
2028-09-30$26M$26M$26M1
2028-12-31$29M$29M$29M1
2029-12-31$119M$121M$124M3

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$-2.19$-2.01$-1.866
2027-03-31$-0.49$-0.48$-0.481
2027-06-30$-0.48$-0.47$-0.471
2027-09-30$-0.44$-0.43$-0.431
2027-12-31$-0.42$-0.42$-0.411
2028-03-31$-0.55$-0.54$-0.542
2028-06-30$-0.50$-0.49$-0.492
2028-09-30$-0.47$-0.46$-0.462
2028-12-31$-0.41$-0.40$-0.402
2029-12-31$-1.43$-1.38$-1.352

Frequently Asked Questions

What is the analyst consensus for CVRX?

The consensus among 2 analysts covering CVRx, Inc. (CVRX) is Buy with an average price target of $10.00.

What is the highest price target for CVRX?

The highest analyst price target for CVRX is $10.00.

What is the lowest price target for CVRX?

The lowest analyst price target for CVRX is $10.00.

How many analysts cover CVRX?

2 analysts have issued ratings for CVRx, Inc. in the past 12 months.

Is CVRX a buy or sell right now?

Based on 2 analyst ratings, CVRX has a consensus rating of Buy (2.00/5) with a +127.0% upside to the consensus target of $10.00.

What are the earnings estimates for CVRX?

Analysts estimate CVRX will report EPS of $-2.01 for the period ending 2026-12-31, with revenue estimated at $65M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.